Extrusion International USA 2-2020

25 Extrusion International 2/2020 Find Solutions to Sorting Challenges Deep learning is on the rise in the recycling industry, ac- cording to the new eBook “Harnessing the Potential of AI” from the global leader in sensor-based sorting, TOMRA Sort- ing Recycling. Dispelling a common misconception about AI, this latest TOMRA eBook chronicles the long, 30-year history TOMRA Sorting Recycling www.tomra.com/recycling and contributions AI has already made to the recycling indus- try, as well the bright future that lies ahead. “In the months and years to come, those in the recycling in- dustry will hear much more about deep learning, a power- ful component of Artificial Intelligence,” says Daniel Bend- er, Technical Manager, Deep Learning for TOMRA Sorting. “Deep learning shows the promise of providing solutions for the industry’s most complex sorting challenges. Recycling op- erations at the forefront of using AI to sort material stand to gain a significant advantage over companies who do not.” The free-to-download eBook goes into detail of how deep learning works and learns to identify materials to resolve problems not solvable with classical machine learning. The book claims deep learning holds the key for achieving more consistent detection rates than manual sorting, elevating material purity while lowering costs. To download the English copy of the new TOMRA eBook on AI and Deep learning, please visit https://solutions.tomra. com/ai-ebook FDA Approval for Pharmaceutical Package Leak Testing received Pfeiffer Vacuum has announced that the ATC by Pfeiffer Vacuum Mass Extraction leak testing process meets FDA standard F3287 for leak testing. This shortens the FDA ap- proval process for pharmaceutical products that require leak testing significantly. Companies that utilize the ATC leak testing process will save hundreds of hours of paperwork for the approval application. When a pharmaceutical company launches a new product or changes an existing product, FDA approval is required. Nor- mally, companies have to submit extensive documentation. However, with ATC being added to the FDA standard, com- panies do not need to submit paperwork regarding leak test, test procedure, water ingress, and package testing manufac- turers can simply declare that their product is leak tested in accordance with FDA F3287 by using ATC equipment, thus adhering to the standard. “It is a tremendous advantage for companies in the pharma- ceutical market that utilize ATC’s technology since they save time and costs,” said Brian Pahl, President of the ATC by Pfei- ffer Vacuum product line. USP 1207 and ASTM (F-3287-17) recognized ATCMass Extrac- tion Technology works on the principle of rarefied gas flow. Pfeiffer Vacuum GmbH www.pfeiffer-vacuum.com Testing takes place in vacuum conditions to attain higher sensitivity. This patented technology is particularly suitable for pharmaceutical packaging such as IV-bags, pouches or glass vials. Larger defects and defects as small as 1 μm can be detected with this method. The technology is thereby suit- able for laboratory applications as well as for use in produc- tion environments allowing stability control as well as 100% automated testing (also in inline machines). FDA laboratories in the US and major pharmaceutical companies have been using the Mass Extraction instruments for over 10 years. Mass Extraction test instrument ME2 fromATC by Pfeiffer Vacuum